Core Viewpoint - Jinxin Reproductive Medicine (01951.HK) has conducted share buybacks for six consecutive days, totaling 30.946 million shares repurchased, amounting to HKD 77.515 million [1] Buyback Details - On December 12, the company repurchased 7.722 million shares at prices ranging from HKD 2.460 to HKD 2.530, with a total buyback amount of HKD 19.352 million [1] - The stock closed at HKD 2.510 on the same day, reflecting a 3.29% increase, with total trading volume of HKD 65.944 million [1] - Cumulatively, since December 5, the stock has increased by 0.40% during the buyback period [1] Buyback Summary Table - The buyback details are as follows: - December 12: 772.20 thousand shares, max price HKD 2.530, min price HKD 2.460, total amount HKD 19.352 million - December 11: 384.60 thousand shares, max price HKD 2.530, min price HKD 2.430, total amount HKD 9.542 million - December 10: 192.55 thousand shares, max price HKD 2.490, min price HKD 2.430, total amount HKD 4.766 million - December 9: 380.20 thousand shares, max price HKD 2.500, min price HKD 2.400, total amount HKD 9.208 million - December 8: 592.85 thousand shares, max price HKD 2.580, min price HKD 2.470, total amount HKD 14.849 million - December 5: 772.20 thousand shares, max price HKD 2.580, min price HKD 2.550, total amount HKD 19.798 million [1]
锦欣生殖(01951.HK)连续6日回购，累计回购3094.60万股